Leconte Medical Center | |
742 Middlecreek Road, Sevierville, Tennessee 37862 | |
(865) 446-7500 | |
Name | Leconte Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 742 Middlecreek Road, Sevierville, Tennessee |
Ownership | Voluntary non-profit - Other |
Emergency Services | Yes |
Medicare ID (CCN) | 440081 |
NPI Number | 1306284484 |
Organization Name | LECONTE MEDICAL CENTER |
Address | 742 Middle Creek Rd, Sevierville, TN 37862 |
Hospital Type | General Acute Care Hospital |
Phone Number | 865-446-8200 |
News Archive
Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
One year ago, study results were presented addressing the reading performance in children with otitis media in early childhood. The findings revealed that middle ear diseases during early years and the attendant hearing losses adversely affect reading performance in first and second graders.
Standard Register Healthcare (NYSE:SR) in partnership with the National Patient Safety Foundation's Lucian Leape Institute announced that nominations have opened for the first annual John Q. Sherman Award for Excellence in Patient Engagement.
› Verified 9 days ago
NPI Number | 1528052578 |
Organization Name | LECONTE MEDICAL CENTER |
Address | 742 Middle Creek Rd, Sevierville, TN 37862 |
Hospital Type | General Acute Care Hospital |
Phone Number | 865-429-6100 |
News Archive
Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
One year ago, study results were presented addressing the reading performance in children with otitis media in early childhood. The findings revealed that middle ear diseases during early years and the attendant hearing losses adversely affect reading performance in first and second graders.
Standard Register Healthcare (NYSE:SR) in partnership with the National Patient Safety Foundation's Lucian Leape Institute announced that nominations have opened for the first annual John Q. Sherman Award for Excellence in Patient Engagement.
› Verified 9 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.
Researchers at Case Western Reserve University School of Medicine and the Ireland Cancer Center of University Hospitals of Cleveland report identifying a new DNA gene marker, vimentin, that was shown in a recent study to be three times more effective in detecting colon cancer than the standard doctor's office test that detects blood in the stool.
One year ago, study results were presented addressing the reading performance in children with otitis media in early childhood. The findings revealed that middle ear diseases during early years and the attendant hearing losses adversely affect reading performance in first and second graders.
Standard Register Healthcare (NYSE:SR) in partnership with the National Patient Safety Foundation's Lucian Leape Institute announced that nominations have opened for the first annual John Q. Sherman Award for Excellence in Patient Engagement.
› Verified 9 days ago
Leconte Medical Center Acute Care Hospital Location: 742 Middlecreek Road, Sevierville, Tennessee 37862 Phone: (865) 446-7500 |